| Symbol |
Name |
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ADORA3
|
adenosine A3 receptor
|
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle)
|
|
ANO2
|
anoctamin 2, calcium activated chloride channel
|
|
AR
|
androgen receptor
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB1
|
arrestin, beta 1
|
|
ATF6
|
activating transcription factor 6
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
BAX
|
BCL2-associated X protein
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
C16ORF58
|
chromosome 16 open reading frame 58
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCND1
|
cyclin D1
|
|
CDC42
|
cell division cycle 42
|
|
CDH13
|
cadherin 13
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLEC9A
|
C-type lectin domain family 9, member A
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
CYTH2
|
cytohesin 2
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DHX36
|
DEAH (Asp-Glu-Ala-His) box polypeptide 36
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
|
DNM1L
|
dynamin 1-like
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPO
|
erythropoietin
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FBXL5
|
F-box and leucine-rich repeat protein 5
|
|
FLCN
|
folliculin
|
|
FNIP1
|
folliculin interacting protein 1
|
|
FOXA2
|
forkhead box A2
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FTO
|
fat mass and obesity associated
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
ING2
|
inhibitor of growth family, member 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
LTB4R
|
leukotriene B4 receptor
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MB21D1
|
Mab-21 domain containing 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR539
|
microRNA 539
|
|
MLXIP
|
MLX interacting protein
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYO1A
|
myosin IA
|
|
MYO1B
|
myosin IB
|
|
MYO1C
|
myosin IC
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NPC1L1
|
NPC1-like 1
|
|
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PKD1L3
|
polycystic kidney disease 1-like 3
|
|
PKD2L1
|
polycystic kidney disease 2-like 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PML
|
promyelocytic leukemia
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHOH
|
ras homolog family member H
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCNN1D
|
sodium channel, non voltage gated 1 delta subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SENP3
|
SUMO1/sentrin/SMT3 specific peptidase 3
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT3
|
sirtuin 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SQSTM1
|
sequestosome 1
|
|
SST
|
somatostatin
|
|
STIM1
|
stromal interaction molecule 1
|
|
TFR2
|
transferrin receptor 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM173
|
transmembrane protein 173
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VWF
|
von Willebrand factor
|
|
ZBP1
|
Z-DNA binding protein 1
|
